Effect of synthetic matrix metalloproteinase inhibitors on lipopolysaccharide-induced blood–brain barrier opening in rodents: Differences in response based on strains and solvents
- 20 December 2006
- journal article
- Published by Elsevier in Brain Research
- Vol. 1133 (1), 186-192
- https://doi.org/10.1016/j.brainres.2006.11.041
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Diazoxide and dimethyl sulphoxide alleviate experimental cerebral hypoperfusion-induced white matter injury in the rat brainNeuroscience Letters, 2005
- Strategies for MMP inhibition in cancer: innovations for the post-trial eraNature Reviews Cancer, 2002
- Matrix metalloproteinases in neuroinflammationGlia, 2002
- The Toll-Like Receptor TLR4 Is Necessary for Lipopolysaccharide-Induced Oligodendrocyte Injury in the CNSJournal of Neuroscience, 2002
- Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitisBrain, 2001
- Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington diseaseNature Medicine, 2000
- Matrix Metalloproteinases: Biologic Activity and Clinical ImplicationsJournal of Clinical Oncology, 2000
- Matrix Metalloproteinases and TIMPs Are Associated With Blood-Brain Barrier Opening After Reperfusion in Rat BrainStroke, 1998
- Gelatinase B modulates selective opening of the blood-brain barrier during inflammationAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 1998
- Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases.Journal of Clinical Investigation, 1994